Document is current
Any future updates will be listed below
-
Authors
Chong, Luke https://orcid.org/0000-0003-2649-2608
Gopinathannair, Rakesh https://orcid.org/0000-0003-4611-3687
Ahmad, Ali
Mar, Philip https://orcid.org/0000-0002-3576-0435
Olshansky, Brian https://orcid.org/0000-0002-6044-045X
- License Information
-
More Information
Article History
Accepted: 13 June 2022
First Online: 18 July 2022
Declarations
:
: Luke Chong MD, Ali Ahmad MD, and Philip Mar MD, PharmD do not have any conflicts of interests to disclose. Brian Olshansky MD, FHRS has served as a consultant for Sanofi Aventis, a consultant and speaker for Lundbeck, a coordinator for Boehringer Ingelheim (US Co-coordinator GLORIA AF), and on the data safety and monitoring board for Amarin (DSMB REDUCE-IT) and Astra Zeneca (DSMB azDIALYZEd). Rakesh Gopinathannair MD, MA, FHRS has served as a consultant and speaker for Abbott Medical, Boston Scientific, Sanofi, and Zoll Medical, and has also served on the advisory board for PaceMate.
